CARDIOMYOPATHY IN CT. Hans- Christoph Becker Professor of Radiology

Similar documents
Etiology, Classification & Management. Sheba Medical Center Cardiology Department Matthew Wright St. George s University of London

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement

4/11/2017. Cardiomyopathy. John Steuter, MD Bryan Heart. Disclosures. No Conflicts. Cardiomyopathy. WHO Classification

Cardiomyopathy: The Good, the Bad.and the Insurable?

Cardiac MRI: Cardiomyopathy

Sudden cardiac death: Primary and secondary prevention

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125

Cardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Is it HF secondary to rheumatic heart disease???

DELAYED ENHANCEMENT IMAGING IN CHILDREN

Treatment of Hypertrophic Cardiomyopathy in Bruce B. Reid, MD

Anaesthesia for non-cardiac surgery in patients left ventricular outflow tract obstruction (LVOTO)

Case based learning: CMR in Heart Failure

CT for Myocardial Characterization of Cardiomyopathy. Byoung Wook Choi, Yonsei University Severance Hospital, Seoul, Korea

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

Cardiomyopathy Consequences. function of the myocardium for any reason. This is a serious disease in which the heart muscle

HYPERTROPHIC CARDIOMYOPATHY

The Management of HOCM: What are the Surgical Options

Ablative Therapy for Ventricular Tachycardia

Το ΗΚΓ στις Μυοκαρδιοπάθειες και στην Περικαρδίτιδα

Takotsubo cardiomyopathy. Joseph L. Blackshear, MD Professor of Medicine Mayo Clinic College of Medicine Mayo Clinic Florida

Why Cardiac MRI? Presented by:

Apical Hypertrophic Cardiomyopathy With Hemodynamically Unstable Ventricular Arrhythmia Atypical Presentation

Cardiac Imaging Tests

Arrhythmias (II) Ventricular Arrhythmias. Disclosures

Exercise Test: Practice and Interpretation. Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine

Advances in Ablation Therapy for Ventricular Tachycardia

XVth Balkan Congress of Radiology Danubius Hotel Helia, October 2017, Budapest, Hungary

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

Steel vs Alcohol. Or Neither. Management of Hypertrophic Cardiomyopathy. Josh Doll, MD January 24, 2015

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Advanced Imaging MRI and CTA

Diploma in Electrocardiography

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS

ADVANCED CARDIOVASCULAR IMAGING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational

9/23/2011. Cardiac MRI Evaluation of Cardiomyopathy and Myocarditis. Primary Hypertrophic Cardiomyopathy. Cardiomyopathy.

cardiomyopathy. INTRODUCTION NONISCHEMIC CARDIOMYOPATHY

Genetic Cardiomyopathies

2

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

Cardiomyopathies. Andre Keren, MD

If you woke up breathing this morning, Congratulations! You get another chance. Use it wisely!

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview

What s new in Hypertrophic Cardiomyopathy?

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

Cardiac Arrhythmias. Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company

December 2018 Tracings

Acute Coronary Syndromes Unstable Angina Non ST segment Elevation MI (NSTEMI) ST segment Elevation MI (STEMI)

Tachycardia-induced heart failure - Does it exist?

Presenter Disclosure Information

Cardiac Issues in the Adolescent Athlete. Sean Levchuck, M.D. St. Francis Hospital- The Heart Center

Skin supplied by T1-4 (medial upper arm and neck) T5-9- epigastrium Visceral afferents from skin and heart are the same dorsal root ganglio

2) Heart Arrhythmias 2 - Dr. Abdullah Sharif

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

My Patient Needs a Stress Test

Cardiomyopathy. ACOI IM Board Review 2018 Martin C. Burke DO, FACOI

Imaging congestive heart failure: role of coronary computed tomography angiography (CCTA)

Appropriate Use Criteria for Initial Transthoracic Echocardiography in Outpatient Pediatric Cardiology (scores listed by Appropriate Use rating)

Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009

Cardiac Considerations and Care in Children with Neuromuscular Disorders

Listing Form: Heart or Cardiovascular Impairments. Medical Provider:

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Paroxysmal Supraventricular Tachycardia PSVT.

Stress, strain and contrast. UK available agents. Safety 13/06/2018. Which enhancing agent do you use? Ultrasound enhancing agents.

Ventricular tachycardia and ischemia. Martin Jan Schalij Department of Cardiology Leiden University Medical Center

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Isolated congenital coronary anomalies: Evaluation by multislice-ct or MRI

Slide 1. Slide 2. Slide 3. Sudden Cardiac Death In Athletes. Epidemiology. Epidemiology. Shaun McMurtry, MD Primary Care Sports Medicine

Medical Policy and and and and

Detailed Order Request Checklists for Cardiology

Cardiac Imaging. Kimberly Delcour, DO, FACC. Mahi Ashwath, MD, FACC, FASE. Director, Cardiac CT. Director, Cardiac MRI

ECG Workshop. Nezar Amir

An Approach to the Patient with Syncope. Guy Amit MD, MPH Soroka University Medical Center Beer-Sheva

Coronary Artery Anomalies from Birth to Adulthood; the Role of CT Coronary Angiography in Sudden Cardiac Death Screening

Treatment of VT of Purkinje fiber origin: ablation targets and outcome

Arrhythmogenic Cardiomyopathy cases. Δέσποινα Παρχαρίδου Καρδιολόγος Επιστημονικός Συνεργάτης Α Καρδιολογική κλινική ΑΧΕΠΑ

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Pregnancy and Heart Disease. Alexandra A Frogoudaki Adult Congenital Heart Clinic ATTIKON University Hospital

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

Two Cardiology Zebras ERIC MARTIN MD

Arrhythmia 341. Ahmad Hersi Professor of Cardiology KSU

Heart Rhythm Disorders. How do you quantify risk?

HEART CONDITIONS IN SPORT

Role of CMR in heart failure and cardiomyopathy

Heart Disorders. Cardiovascular Disorders (Part B-1) Module 5 -Chapter 8. Overview Heart Disorders Vascular Disorders

Update on use of cardiac MRI in ARVC/D. Stefan L. Zimmerman, MD Johns Hopkins University Department of Radiology

CONGENITAL CORONARY ARTERY ANOMALIES

Ventricular Tachycardia in Structurally Normal Hearts (Idiopathic VT) Patient Information

MANAGEMENT OF ASYMPTOMATIC BRADYCARDIA. Pr. HABIB HAOUALA Service de Cardiologie Hôpital militaire de Tunis

Disclosures. GETTING TO THE HEART OF THE MATTER WITH MULTIMODALITY CARDIAC IMAGING Organ Review Meeting 25 September. Overview

Pushing the limits of cardiac CT. Steven Dymarkowski Radiology / Medical Imaging Research Centre

Hypertrophic Cardiomyopathy: beyond gradient and wall thickness

ESC Guidelines on Hypertrophic Cardiomyopathy

Pearls & Pitfalls in nuclear cardiology

Disclosures. Case Based Review of Cardiovascular MRI. Double IR black blood FSE/TSE

12 Lead ECG Interpretation

DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY. David SIU MD ( 蕭頌華醫生 ) Division of Cardiology The University of Hong Kong

Transcription:

CARDIOMYOPATHY IN CT Hans- Christoph Becker Professor of Radiology 1

Cardiomyopathy Heart muscle disease Deterioration of the heart function, heart failure Dyspnea, peripheral edema Risk of arrhythmia, sudden cardiac death

Cardiomyopathy Classification

Primary/Intrinsic CM Genetic HOCM, ARVD, NCC, Mitochondrial Myopathy Mixed DCM, RCM Loeffler endocarditis Acquired Peripartum Takotsubo

Secondary/Extrinsic CM Metabolic Amyloidosis, hemachromatosis Inflammatory Viral, Chagas disease Endocrine Diabetes, hyperthyroidism, acromegaly Toxic CTx, alcohol Neuromuscular Muscular dystrophy Other Ischemic, nutritional

Cardiac CT Scan Modes Retrospective Spiral Prospective Sequence Single Heart Beat Heart rate Any Any <60 bmp Rhythm Any Sinus Sinus Radiation <20 msv <4 msv <1 msv Function Yes Optional No

Williams Clinical Radiology 2008 normal LV thickness 7-11 mm

anterior LAD posterior RCA lateral LCx

Myocardial Perfusion CTA MBV MBF

Dilated Cardiomyopathy (DCM) Most common non ischemic CM, predominant African-Americans Viral (Coxsackie B, enterovirus) myocarditis, Chagas disease Peripartum CM Alcohol, chemotherapy (doxorubicin) Thyroid disease, chronic uncontrolled tachycardia (Autoimmune)

Dilated Cardiomyopathy non apposition in end systolic phase Williams Clinical Radiology 2008

Dilated Cardiomyopathy (DCM) Breathlessness (pulmonary edema), syncope, angina Left ventricular remodeling, increase of ED & ES, decline of EF Death due to congestive heart failure, tachy- or bradyarrhythmia ACE inhibitor, diuretics, digitalis, anticoagulation Pacemaker, cardioverter defibrillator, HTX

Andreini JACC 2007

MDCT in DCM 132 consecutive DCM patients 2 patients (1.5%) MDCT not feasible (AF) 88 normal and 42 diseased coronary arteries in MDCT & ICA Except for 1 all correctly classified by MDCT 1-vessel (11), 2-vessel (13), and 3-vessel (18) disease Andreini Circ Cardiovasc Imaging 2009

ischemic ideopathic Andreini JACC 2007

MDCT for the DD of DCM 61 DCM versus 139 patients with normal function 10 complications associated with conventional angiography No MDCT-related complications Coronary artery visualization was 97.2% Interference from a hypertrophic cardiac venous system MDCT is feasible, safe, and accurate for identification of idiopathic versus ischemic DCM, and may represent an alternative to coronary angiography. Andreini JACC 2007

Ischemic Cardiomyopathy acute MI chronic MI Nikolaou JCAT 2004

Late Myocardial Enhancement First Pass Late Enhancement Late Enhancement Mahnken Eur Radiol 2006

CT post Coronary Interventions Habis JACC 2007

Restrictive Cardiomyopathy Aras Int J Cardiovasc Imaging 2006

Myocardial Calcification Deranged Ca 3 (PO 4 ) 2 Chronic renal failure Hyperparathyreoidism Myocardial infarction Normal Ca 3 (PO 4 ) 2 Myocarditis (Tbc, Streptococcus, ) Endomyocardial fibrosis Irradiation Rare cardiac tumors

a b 47 YOM end stage renal disease hemodialysis, refractory laboratory values, poor dietary compliance Matsui Cardiorenal Medicine 2012 1 year 1 month prior presentation

Metastatic Myocardial Calcification a a b b Matsui Cardiorenal Medicine 2012

Hypertrophic (Obstructive) CM HCM/HOCM Incidence 0.2-0.5% Autosomal dominant disease (mutation of sarcomeric genes) Myofibrillar disarray with patchy areas of necrotic tissue Dyspnoe, chest pain, palpitations, syncope, sudden cardiac death 2/3 asymmetric septal hypertrophy Myectomy, septal alcohol ablation, ventricular pacing, HTX

Hypertrophic Obstructive Cardiomyopathy Systolic anterior movement SAM Ghersin Circulation 2011

Septal Alcohol Ablation Ghersin Circulation 2011

Alcohol Septal Ablation Mitsutake IJC 2008

Non Compaction Cardiomyopathy Kirsch IJC 2007 (NCCM)

Non Compaction Cardiomyopathy Congenital genetic cardiomyopathy Incidence 0.12/100,000 (underdiagnosed) Spongelike meshwork of myocardial fibers (NC:C = 2:1) Breathlessness, swelling of ankles, limited physical capacity Tachyarrhythmia, sudden death, clotting of blood ACE inhibitor, beta-blocker, aspirin, valve surgery, HTX

Myocardial Non Compaction Williams Clinical Radiology 2008

Arrhythmogenic Right Ventricular Dysplasia (ARVD) Autosomal dominant CM of the desmosomes (cell link) (Fibro)fatty replacement of the RV myocardium with arrhythmia Incidence 1 (US) - 40 (I) /10,000, 17% of sudden death in young Palpitations, syncope, lower extremity edema, liver congestion, sudden death Beta-blocker, amiodarone, warfarin, catheter ablation, defibrillator, HTX

Arrhythmogenic Right Ventricular Dysplasia

Criteria for ARVD Diagnosis Major Minor RV dysfunction Severe RV dilation/reduced EF Localized RV aneurysm Severe segmental RV dilatation Mild global RV dilatation/reduced EF Mild segmental RV dilatation Regional RV hypokinesia Tissue characterization Fibrofatty replacement by biopsy - Conduction abnormalities Epsilon waves, QRS prolongation Inverted T, VT, frequent pvc Family history Confirmed by autopy Sudden death <35 years

Takotsubo Cardiomyopathy Transient vasospasm, microvascular dysfunction Chest pain, dyspnea Pathognomonic wall motion abnormality (apical ballooning) Intra-aortic balloon pump, fluids, beta blocker, calcium channel blockers LV function normalizes within 2 months

Takotsubo CM

Cardiomyopathies in CT Dilated cardiomyopathy Coronary CT angiography Porcelain/pottery heart, non compaction CM Prospectively ECG triggered HOCM, ARVD, Takotsubo CM, DCM Retrospectively ECG gated 16